Susan Mahony, SVP & President, Lilly Oncology at LILLY ELI & CO (LLY), sold 41,221 shares at $72.65 ($2.9M) on 2016-12-16, disclosed to the SEC on 2016-12-19.
Open-market sale of $2.9M LLY by SVP & President, Lilly Oncology. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 737 | $0 | 0.0% |
| 2 | $72.65 | 19,093 | $1.4M | 47.2% |
| 3 | $72.65 | 19,093 | $1.4M | 47.2% |
| 4 | $72.68 | 1,149 | $84K | 2.8% |
| 5 | $72.68 | 1,149 | $84K | 2.8% |
| Total | $71.35 avg | 41,221 |
| $2.9M |
| 100% |
| Filing → |
| LLY | SELL | 2017-12-05 | $6.3M | — | Filing → |
| LLY | SELL | 2015-07-29 | $2.1M | — | Filing → |
| LLY | SELL | 2014-07-30 | $131K | — | Filing → |